MN-221
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MN-221, covering 2011-07-29 to 2015-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]